Total Return chart Alzinova AB

Stocks

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2026-07-07 EDT			5-day change	1st Jan Change
1.400 ^SEK	+191.67%		+182.26%	+68.88%

06-24	Alzinova AB and Fujirebio Enter Letter of Intent for Potential Commercialization of Blood-Based Alzheimer?S Diagnostic Test	CI
06-24	Alzinova Inks Nonbinding Deal with Fujirebio for Potential Alzheimer's Blood-based Diagnostic Test	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.